Early diagnosis and treatment of metabolic dysfunction‐associated steatotic liver disease (MASLD) remains a significant challenge.[26] Current research is focused on understanding the mechanisms of lipid metabolism in hepatocytes within the context of MASLD.[27] This study has unveiled a new mechanism involving LIMA1 in hepatocyte lipid deposition and MASLD progression. This evidence concerns the gene LIMA1 and liver disorder.